Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 9/20 | 0.35 |
| ▸ | EGFR | P00533 | 5/20 | 0.35 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.33 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | RET | P07949 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31639020 | 0.89 | BTK (0.37) | BTKEGFRCXCR2ADORA2AHDAC3 | |
| SCHEMBL31638874 | 0.89 | CXCR2 (0.37) | BTKEGFRUCHL1CXCR2MET | |
| SCHEMBL31638854 | 0.88 | BTK (0.34) | BTKEGFRUCHL1CXCR2 | |
| SCHEMBL31638968 | 0.86 | EGFR (0.38) | BTKEGFRADORA2AMETHDAC3 | |
| SCHEMBL31638766 | 0.77 | ROCK2 (0.41) | BTKEGFRMET | |
| SCHEMBL31638790 | 0.77 | ROCK2 (0.40) | BTKEGFRMETHDAC3HDAC1 | |
| SCHEMBL31638930 | 0.77 | ROCK2 (0.41) | BTKEGFRMET | |
| SCHEMBL31638952 | 0.77 | ROCK2 (0.41) | BTKEGFRMET | |
| SCHEMBL31638929 | 0.77 | ROCK2 (0.41) | BTKEGFRMET | |
| SCHEMBL31638940 | 0.76 | ROCK2 (0.36) | BTKEGFRMETHDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025137329-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | NEUPHARMA, INC (US) | 2025-06-26 | — | — | WO | disclosed |